That really shows an underlying value in the company's IP/assets, and the fact the company values their future prospects much higher than the current market cap, especially when looking at the money and time spent on getting FDA approval in the first place for FebriDx. Something which isn't really reflected in the current share price.
- Forums
- ASX - By Stock
- Ann: Q2 FY25 Results Investor Briefing Invitation
LDX
lumos diagnostics holdings limited
Add to My Watchlist
0.00%
!
7.3¢

That really shows an underlying value in the company's...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.64M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1209 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 44000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1209 | 0.077 |
1 | 133320 | 0.075 |
3 | 258486 | 0.074 |
3 | 207191 | 0.073 |
2 | 200000 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 44000 | 1 |
0.073 | 384016 | 3 |
0.074 | 210182 | 3 |
0.075 | 1349494 | 3 |
0.076 | 480228 | 8 |
Last trade - 09.53am 31/07/2025 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |